Comparative bioavailability of three brands of ampicillin.
The relative biological availability (bioavailability) of three brands of ampicillin trihydrate capsules marketed in Canada was studied by means of a crossover experimental design and was evaluated by analysis of variance. After administration of a single oral dose (500 mg.) to volunteer subjects, the mean peak ampicillin serum concentration and the area under the time ampicillin serum concentration curve (AUC) were higher for one of the products than for the other two. A second study utilizing the same experimental design revealed no differences in these parameters when different production lots of the more available product were compared. Product bioavailability was not related to the in vitro dissolution time of the capsules. The experimental design and methods of statistical analysis are discussed.
D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D000704:Analysis of Variance; D001702:Biopharmaceutics; D006805:Human Experimentation; D006801:Humans; D007239:Infections / Q000188:drug therapy; D008297:Male; D008722:Methods
D000667:Ampicillin